Annual report pursuant to Section 13 and 15(d)

NATURE OF BUSINESS (Details Narrative)

v3.22.1
NATURE OF BUSINESS (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]      
Proceeds from issues of warrant $ 6,000    
Warrant outstnding percentage 2.00%    
Share price $ 0.52    
Cash and cash equivalents, at carrying value $ 2,300 $ 2,262  
Restricted cash, current 1,700   $ 1,300
Working capital deficit 12,500    
Restaurant Revitalization Fund [Member]      
Restructuring Cost and Reserve [Line Items]      
Unused funds received 2,000    
Escrow deposit $ 500    
Sonnet Bio Therapeutics Inc [Member]      
Restructuring Cost and Reserve [Line Items]      
Stock issued during period shares new issues 186,161    
Share price $ 0.01